ArentFox Schiff has announced the formation of its Longevity & Healthspan Industry Group, a multidisciplinary initiative aimed at supporting companies engaged in anti-aging innovation, wellness, and preventive health. This development reflects the firm’s commitment to addressing the complex legal and regulatory challenges faced by businesses in the rapidly expanding longevity sector.
Gayland O. Hethcoat II, who leads the new group, emphasized the convergence of stakeholders from healthcare, biotechnology, consumer wellness, and technology within the longevity ecosystem. He stated, “Companies in this space face a complex and evolving regulatory environment. Our goal is to serve as a strategic legal partner to innovators building the next generation of health, wellness, and human performance platforms.” ([afslaw.com](https://www.afslaw.com/perspectives/press-releases/arentfox-schiff-launches-first-its-kind-longevity-healthspan-industry?utm_source=openai))
The Longevity & Healthspan Industry Group offers integrated counsel across various sectors, including:
- Biotechnology and life sciences
- Precision diagnostics and direct-to-consumer testing
- Wearable and consumer health technology
- Digital health and AI-powered platforms
- Longevity clinics and preventive care practices
- Nutrition, supplementation, and cosmetic companies
- Fitness, recovery, and performance brands
- Medical travel and wellness tourism
- Long-term care and senior living
- Longevity-focused investors
ArentFox Schiff’s Chairman, Anthony V. Lupo, highlighted the firm’s proactive approach, noting that establishing this dedicated industry group reinforces their focus on staying ahead of trends shaping clients’ businesses. He remarked, “This groundbreaking group unites our health care, regulatory, life sciences, and transactional practices to support clients at the cutting edge of longevity innovation—from stem cells to advances in reverse aging—helping them move bold ideas forward while managing risk.” ([afslaw.com](https://www.afslaw.com/perspectives/press-releases/arentfox-schiff-launches-first-its-kind-longevity-healthspan-industry?utm_source=openai))
The group’s core competencies encompass regulatory compliance, innovative reimbursement strategies, data privacy and governance, intellectual property protection, corporate and transactional matters, and government relations. This comprehensive expertise positions the team to guide clients through various growth stages, from early development and commercialization to scaling, partnerships, and investment.
In recent years, ArentFox Schiff has demonstrated a strategic focus on expanding its capabilities in emerging industries. In June 2024, the firm added a 17-member technology and life sciences team to its Boston office, enhancing its intellectual property and complex litigation services. ([patentlawyermagazine.com](https://patentlawyermagazine.com/arentfox-schiff-adds-17-member-technology-and-life-sciences-industry-team-in-boston/?utm_source=openai))
Additionally, the firm has been proactive in adopting advanced technologies to enhance client services. By integrating generative AI tools, ArentFox Schiff has streamlined legal processes, allowing attorneys to focus more on client advice and less on routine tasks. ([harvey.ai](https://www.harvey.ai/customers/arentfox-schiff?utm_source=openai))
With the launch of the Longevity & Healthspan Industry Group, ArentFox Schiff continues to position itself at the forefront of legal services for innovative sectors, offering comprehensive support to clients navigating the evolving landscape of health and wellness industries.